NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
Rhea-AI Summary
NEXGEL (NASDAQ:NXGL) announced that CEO Adam Levy will present at the Planet MicroCap Conference in Las Vegas from June 16–18, 2026 at the Bellagio Hotel & Casino.
Levy’s presentation is scheduled for Wednesday, June 17, 2026 at 1:30 p.m. PT in Track 3 - Da Vinci 3, with a webcast available via the company’s investor relations site. Investors can also schedule one-on-one meetings by contacting KCSA Strategic Communications at the provided email.
Positive
- None.
Negative
- None.
News Market Reaction – NXGL
In the Jun 4 session, NXGL gained 0.17%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 19 | Clinical study results | Positive | -0.2% | Reported strong hydrogel patch data with 95.6% plume reduction and no AEs. |
| May 13 | Management hire | Positive | -8.1% | Named VP of Sales for BIONX Surgical to drive commercialization growth. |
| May 12 | Earnings timing | Neutral | -4.1% | Announced date and time for Q1 2026 financial results conference call. |
| May 06 | Board, financing | Positive | +1.6% | Added Sequence LifeScience executives to board with a $5.5M strategic investment. |
| Apr 27 | CFO appointment | Positive | -6.0% | Appointed new CFO to support Celularity asset acquisition and business scaling. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows several positive operational and strategic announcements followed by negative 24-hour price moves, indicating a pattern of muted or contrary reactions to good news.
Over the last few months, NEXGEL has focused on clinical validation, leadership build‑out, and strategic expansion. Positive hydrogel study data, new sales leadership for BIONX Surgical, and board additions linked to a $5.5 million strategic investment highlight growth ambitions. Management changes, including a new CFO, support integration of acquired Celularity assets. Against this backdrop, today’s conference appearance announcement fits into broader efforts to increase investor outreach and support commercialization momentum.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LANGHORNE, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Planet MicroCap Conference on June 16 – 18, 2026, in Las Vegas, NV.
Planet MicroCap Las Vegas 2026
Dates: June 16-18, 2026
Location: Bellagio Hotel & Casino, Las Vegas, NV
Booth: #517
Presentation Day and Time: Wednesday, June 17, 2026, at 1:30 P.M. PT
Presentation Location: Track 3 - Da Vinci 3
Webcast: https://ir.nexgel.com/news-events/events-presentations
To schedule a one-on-one investor meeting with Mr. Levy, please contact KCSA Strategic Communications at Nexgel@kcsa.com.
About NEXGEL, INC.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@kcsa.com
